Nobel Prize-Winner’s Stem Cells Help Glaxo Pinpoint Risks

GlaxoSmithKline Plc is applying Shinya Yamanaka’s Nobel Prize-winning discovery in stem cells to identify heart risks linked to experimental drugs earlier in the development process.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.